# Capitainer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/capitainer

- Industry: Medical Devices & Equipment
- Headquarters: Solna, Sweden
- Website: www.capitainer.se
- Total disclosed funding: $4.8M
- Latest round: Series A (Feb 15, 2024)
- Investors on record: 2

## About

Based in Stockholm, Sweden, and founded in 2016, Capitainer AB operates as a medical devices company offering microsystem-based technology to perform blood sampling and testing at home. In February 2024, Capitainer AB raised SEK 50 million in series A funding led by investor Dynamics Venture Management, with participation from another investor Sciety. The firm as of June 2024, is led by its CEO, Christopher Aulin. 

The company’s products include the Capitainer®B, Capitainer®B 50, and Capitainer®B Vanadate, which are designed for accurate blood self-sampling using qDBS technology, enabling users to send samples to laboratories through regular mail. Capitainer's devices ensure quantitative sampling with the accuracy and precision of traditional methods while protecting samples from contamination. The products cater to various needs, from general biomarker analysis to specific tests like PEth for alcohol markers. This technology is particularly beneficial for large-scale screening projects and has been instrumental in COVID-19 serology testing.

The company plans to utilize the February 2024 funding to increase its operations, which will include adding new items, improving sales and marketing plans, and increasing production capacity.

## Funding rounds

- Series A, Feb 15, 2024, $4.8M — Dynamics Venture Management, Sciety

## Investors

- Dynamics Venture Management (https://capitalatlas.ai/funds/dynamics-venture-management) — Series A
- Sciety (https://capitalatlas.ai/funds/sciety) — Series A